Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Satellos Bioscience Inc Com V.ICO


Primary Symbol: ICOTF

Healthcare Biotechnology
iCo Therapeutics Inc is a Canada based biotechnology company. It is involved in the Research and development of ophthalmic indications. The company identifies, develops, and commercialize drug candidates with clinical history, and re-doses, reformulates and develops these drug candidates to treat sight and life-threatening diseases. Its in-licensed assets are iCo-008 and the Oral AmpB Delivery System. iCo-008 is a human monoclonal antibody targeting eotaxin-1 that acts as a messenger between...


GREY:ICOTF - Post by User

Satellos Bioscience Inc Com > THe REaL INFeCTION
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(16)
•••
Comment by kindvalueon Apr 07, 2020 9:44pm
194 Views
Post# 30888872

RE:RE:THe REaL INFeCTION

RE:RE:THe REaL INFeCTIONmy main point is forget covid
the other assets have value and the stock is very cheap
008 / occular - ideally the company pursues developing as occular is the best indication and Alexion really missed out by not securing - other pharmas would like to partner on this but best they do some development work then find a partner
Amp B data soon and the stock has ripped on positive data before so watch out - could be big 
Alexion should just buy ICO - perhaps they were in the market today as that was good volume
but why should they pay $6M on BERT milestone and then pay royalties and still not own 008
JUST BUY ICO



<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities